Ed Esplin
“I anticipate the vaccine strategy for COVID-19, supported by the tremendous advances in vaccine technology and development made in the past 3 years, transitioning to something akin to what is done for influenza A/B, with annual development of a vaccine tailored to the strain(s) of COVID-19 predicted to predominate in a particular ‘COVID season.’” Banner […]
Read More